Home/Filings/4/0001193125-25-283953
4//SEC Filing

Hunt Jonathan Robert 4

Accession 0001193125-25-283953

CIK 0000728387other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 8:01 AM ET

Size

5.3 KB

Accession

0001193125-25-283953

Insider Transaction Report

Form 4
Period: 2025-11-13
Hunt Jonathan Robert
Chief Accounting Officer
Transactions
  • Purchase

    Common Stock

    2025-11-13$2.03/sh+11,000$22,29559,800 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.0235 to $2.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.

Documents

1 file

Issuer

Perspective Therapeutics, Inc.

CIK 0000728387

Entity typeother

Related Parties

1
  • filerCIK 0001375410

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:01 AM ET
Size
5.3 KB